Optimizing patients with non-alcoholic fatty liver disease pre-transplant [0.03%]
移植前非酒精性脂肪肝病患者的优化治疗
Amine Benmassaoud,Marc Deschenes,Tianyan Chen et al.
Amine Benmassaoud et al.
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries. Non-alcoholic steatohepatitis (NASH), which is the progressive counterpart of the disease, is becoming the leading indication ...
Congenital absence of the portal vein: Define the portosystemic shunt, avoid liver transplantation [0.03%]
先天性门静脉缺失：定义门体分流，避免肝移植
Noémie Laverdure,Michel Lallier,Josée Dubois et al.
Noémie Laverdure et al.
Liver transplantation has been historically recommended for patients with congenital absence of the portal vein associated with extrahepatic congenital portosystemic shunts. Here, based on a case report of a 2-year-old girl and a thorough r...
Terlipressin and albumin: The good, the bad, and the unattractive (with apologies to Sergio Leone) [0.03%]
特利加压素与白蛋白：好的、不好的和没有吸引力的（向塞尔吉奥·莱昂内道歉）
Mahmoud Omar,Trana Hussaini,Eric M Yoshida
Mahmoud Omar
Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis [0.03%]
非酒精性脂肪肝病合并慢性病毒性肝炎患者的肝酶和纤维化标志物水平
Micah Grubert Van Iderstine,J Uhanova,Gerald Y Minuk
Micah Grubert Van Iderstine
The impact of non-alcoholic fatty liver disease (NAFLD) on patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections has yet to be determined. In this retrospective, cross-sectional analysis, untreated chronic HBV...
Mandip Rai,Catherine Lowe,Jennifer A Flemming
Mandip Rai
Background: The Canadian Liver Foundation recommends routine hepatitis C (HCV) screening for Canadians born between 1945 and 1975. This study aimed to determine the feasibility and outcomes of targeted birth cohort HCV sc...
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis [0.03%]
酒精使用不影响直接抗病毒治疗的接受率和持续病毒学应答：加拿大肝脏基金会合作研究网络(CANUHC)分析结果
Matt Driedger,Marie-Louise Vachon,Alexander Wong et al.
Matt Driedger et al.
Background: Alcohol use and hepatitis C virus (HCV) are two leading causes of liver disease. Alcohol use is prevalent among the HCV-infected population and accelerates the progression of HCV-related liver disease. Despite...
Hepatic adenomatosis in a young woman with non-familial maturity-onset diabetes of the young type 3 [0.03%]
年轻非青少年发病的成人型糖尿病3型女性患者并发肝腺瘤病
David A Miles,Signy Holmes,Gerald Y Minuk
David A Miles
Hepatic adenomatosis (HA) is a rare condition in which multiple adenomas exist in an otherwise healthy liver. The most common subtype (H-HA) is associated with bi-allelic, somatic hepatic nuclear factor 1-alpha (HNF1A) mutations. Maturity-o...
Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease [0.03%]
非酒精性脂肪肝病患者天冬氨酸氨基转移酶与血小板比值指数和非酒精性脂肪肝病纤维化评分与瞬时弹性成像评分的比较研究
Ben Cox,Roberto Trasolini,Ciaran Galts et al.
Ben Cox et al.
Background: With the rate of non-alcoholic fatty liver disease (NAFLD) on the rise, the necessity of identifying patients at risk of cirrhosis and its complications is becoming ever more important. Liver biopsy remains th...
Demanding truth, reconciliation, and justice for Canada's Indigenous Peoples: Now and forever [0.03%]
đòi hỏi sự thật，和解与正义：为加拿大的原住民永不止步
Natasha Chandok,Eric M Yoshida
Natasha Chandok
Xun Zhao,Ruiyao Huang,Philip Wong et al.
Xun Zhao et al.
The toxic renal accumulation of bile pigment sparked clinical intrigue almost a century ago. More recently, however, the identification of bile casts within renal tubules in patients with liver dysfunction has been largely overlooked. We ha...